Author

A. Daman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Chadburn· 1 shared A. Martinez de Paz· 1 shared A. Ravishankar· 1 shared A. Thibodeau· 1 shared B. Fatou· 1 shared C. M. Bourne· 1 shared C. Parkhurst· 1 shared C. Steidl· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chadburn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenetic Memory of COVID-19 in Innate Immune Cells and Their Progenitors

J. G. Cheong, A. Ravishankar, S. Sharma, C. Parkhurst, D. Nehar-Belaid, S. Ma, L. Paddock, B. Fatou, E. Karakaslar, A. Thibodeau, M. Bale, V. Kartha, J. Yee, M. Y. Mays, L. Leyre, , S. Josefowicz

The paper identifies sustained epigenomic changes in hematopoietic stem and progenitor cells after COVID-19, which influence innate immune cell function and inflammation.

bioRxiv · Feb 9, 2022Immunology

Unmasking the cryptic immunopeptidome of EZH2 mutated diffuse large B-cell lymphomas through combination drug treatment

C. M. Bourne, S. S. Mun, T. Dao, Z. E. H. Aretz, R. S. Gejman, A. Daman, K. Takata, C. Steidl, M. G. Klatt, D. A. Scheinberg

The paper identifies tumor-specific MHC ligands in EZH2-mutated DLBCLs by combining epigenetic drugs and interferon gamma, expanding the immunopeptidome for immunotherapy targets.

bioRxiv · Sep 1, 2021 · PreprintImmunology